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Abstract
Background: Taurine plays an important role in reducing physiological stress. Recent studies indicated that taurine
may serve as an anti-obesity agent at the cellular level. This study characterizes taurine’s potential anti-obesity
function in C. elegans, which have become a popular in vivo model for understanding the regulatory basis of lipid
biosynthesis and deposition.
Methods: Two strains of C. elegans were raised on a normal or high-fat diet: N2 (normal) and RB1600, a mutant in
tub-1 that serves as a tubby homologue and functions parallel to the 3-ketoacyl-CoA thiolase gene (kat-1) in
regulating lipid accumulation. Taurine’s effect on lipid deposition was characterized according to assays of Sudan
black B staining, triglyceride content measurement, food consumption, and mobility comparison.
Results: When N2 was treated with taurine after the culture in the high-fat media, the worms showed lower lipid
accumulation in the assays of the Sudan black B staining and the triglyceride quantification. The anti-obesity effect
was less evident in the experiment for RB1600. When the amount of taurine was increased for the high-fat-diet-
treated N2 strain, fat deposition decreased and mobility increased in a dose-dependent manner. In the food
consumption assays, taurine did not cause a significant change in food intake.
Conclusions: Taken together, these results strongly imply that taurine plays an important role in reducing fat
deposition by modulating cellular pathways for lipid accumulation and stimulating mobility, but not the pathways
for lipid biosynthesis and food intake.
Background
Taurine, or 2-aminoethanesulfonic acid, is the major
component of bile and is present in many types of ani-
mal tissues, including in the gall bladder, blood vessels,
eyes, and lower intestine. Although taurine is less
known as an amino acid, it is commonly used as a func-
tional component of various types of health drinks. It
plays a vital role in adjusting physiological pathways in
antioxidation and detoxification. Recent studies indi-
cated that taurine deficiency is associated with persistent
obesity, which can be prevented by dietary taurine sup-
plementation [1,2]. This study tested taurine’sa n t i -
obesity potential with C. elegans, which are frequently
used as a tractable system in current biomedical
researches [3,4].
C. elegans is a very useful animal system in unearthing
crucial biological mechanisms that are readily applicable
to many higher-level organisms, including humans [5,6].
Indeed, many recently discovered biological pathways of
C. elegans have been proven analogous to those of
mammals, despite its relatively simple body structure
[7-9]. Its short generation period of three days enables
researchers to perform a drug screen with a time advan-
tage over other test systems, including rodents. Unlike
mammals, though, C. elegans lacks leptin-like molecules
and their receptor, which participate in regulating fat
storage. This makes C. elegans attractive to many
researchers who are mass-screening taurine’s potential
as an anti-obesity agent, since C. elegans should provide
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lization that is independent of the hormonal inhibition
of food intake. Under certain circumstances, C. elegans
serves as a tractable system of studying taurine’s effect
on obesity and fat accumulation, and thus, its anti-obe-
sity potential.
Lipid accumulation involves complex processes of
lipid biosynthesis, transport, and storage [10-13]. Lipid
biosynthesis is mainly controlled by sterol regulatory
element-binding proteins (SREBPs). In mammals, stored
fat is consumed according to various transcriptional,
translational, and post-translational regulation processes,
as in mammals. The SREBP cleavage-activating proteins
(SCAPs) are believed to play an important role in acti-
vating SREBPs before the SREBPs’ transport into the
nucleus. The majority of mammalian lipases are homo-
l o g o u st ot h o s ei nC .e l e g a n s .I nC .e l e g a n s ,S B P - 1 ,a n
SREBP homologue, regulates fatty acid homeostasis by
modulating the expression of various lipogenic enzymes.
In C. elegans, the gene products of tub-1 are believed
to manage lipid accumulation in cooperation with those
of kat-1, which govern fatty acid beta-oxidation [14-17].
The tub-1 mutants show an excessive obese phenotype
especially under an impaired kat-1 gene. The level of
fatty acyl-CoA is very important in controlling the rate
of beta-oxidation. Its level is rigorously controlled by
carnitine acyltranferase, which transports acyl-CoA and
its derivatives into the mitochondrion [18-20]. The
enzymatic activity is governed by malonyl-CoA. With
increased levels of acetyl-CoA and citrate, however,
beta-oxidation decreases in a negative feedback.
This study characterized taurine as an anti-obesity
agent in C. elegans that were fed a high-fat diet. The
strains of N2, both the normal and RB1600, that
mutated in the tub-1 gene were tested under four
classes of experiments. The worms were analyzed using
Sudan black B staining, food intake assay, triglyceride
measurement, and mobility assessment.
Methods
Worm culture and taurine treatment
C. elegans were grown on standard nematode-growth
media that contained high or normal content of choles-
terol as 25.0 or 12.5 μM, respectively. During each
experiment, the worms were grown on the nematode
growth media (NGM) that contained E. coli OP50 as a
food source. The taurine-containing media were pre-
pared by smearing an appropriate amount of taurine
stock solution onto the media. The stock of E. coli
OP50 was prepared by culturing it overnight in an LB
medium until concentrated particles were formed. The
quantity of OP50 in the media was adjusted depending
on the initial worm input and the duration of the worm
culture.
Sudan black B staining
The anti-obesity effect of taurine was studied via micro-
scopy on stained worms. Individual worms were fixed
and stained with Sudan black, which stains lipid stores
into opaque blue. For the staining, the worms were
removed from the culture plates and were starved for
6 h. After they were washed in M9 media, they were
fixed with 1% paraformamide in M9. Then they were
subjected to three freeze-thaw cycles and dehydrated in
95% ethanol. The staining was performed in 70% etha-
nol saturated with Sudan black B.
Lipid content measurement
The lipid contents were quantitated by measuring the
triglyceride content of the worms that were treated
under taurine or taurine-free conditions. The worms
were thoroughly washed in TBS and homogenized and
sonicated in a Triglyceride Assay Buffer (TAB) and the
triglyceride content was assessed using a BioVision tri-
glyceride assay kit (Mountain view, CA, USA). After
brief centrifugation, the samples were diluted to a final
volume of 50μl/well. Following the dilution of the sam-
ples in two microliters of lipase, the samples were
incubated for 20 min at room temperature to convert
their triglycerides into glycerol and fatty acid. The
optical density of each of the incubated samples was
measured at 570 nm for the colorimetric assay in a
microplate reader. The calculations were made by sub-
tracting the background value derived from the 0 tri-
glyceride standard from all the sample readings. The
triglyceride concentration (nmol/μl) was calculated
according to the formula [TC] = Ts (nmol) / Sv (μl)
[Ts: amount of triglycerides from the standard curve,
and Sv: sample volume (before dilution) in the sample
wells].
Food consumption assay
Worms were treated on taurine or taurine-free media
for 12 hours; then, they were subjected either to fast or
to copious feeding with OP50 for 6 h on NGM media.
Twenty worms of 1-day-old were transferred onto NGM
plates covered with lawn of identical amount of OP50 (9
X1 0
9 cfu). The time taken for total intake of the food
input was measured and compared among the treatment
and genotypes.
Mobility assay
After the worms’ culture on the tunicamycin-containing
media, they were further grown on taurine-containing
media. The moving distances of the worms that were
treated with various taurine concentrations were visually
compared. The difference in the mobility of the taurine-
treated and the non-taurine-treated worms was observed
in a light box.
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Several experiments were performed to examine the
effect of taurine on fat accumulation in the normal and
tubby strains of C. elegans. Throughout the various
taurine treatments, differences in the lipid accumulation
were evident both qualitatively and quantitatively under
Sudan black staining, food consumption assay, fatty acid
quantification, and mobility comparison analysis.
Fat accumulation decreased under taurine treatment via
Sudan black staining
The anti-obesity effect of taurine was studied under a
microscope. Fig. 1 shows taurine’s effect on lipid sto-
rage, as manifested via Sudan black B staining, after the
worms were treated for 24 h with two different taurine
concentrations. When cultured on a high-fat diet, the
worms appeared to accumulate excess triglyceride in
separate opaque spots that were highly noticeable in the
intestinal and hypodermal tissues. No substantial differ-
ence appeared in the fat stores of the worms that were
treated with a normal diet (data not shown), but notable
differences emerged among the worms that were treated
with a high-fat diet followed by taurine treatment. Taur-
ine’s effect of reducing lipid storage was definite in the
wild-type strain of N2 (upper panel, Fig. 1), but its effect
was minimal or insignificant for tub-1,t h el i p i ds t o r a g e
mutant (lower panel).
The triglyceride level was low in taurine-treated worms
In addition to a visual comparison of the lipid droplet
that was formed in the Sudan black B staining experi-
ment, this experiment assessed the total amount of tri-
glycerides in C. elegans. The measurement that was
performed in this experiment genuinely referred to the
lipid biosynthesis in the worms. The triglyceride content
was shown to correspond to those in the experiment
and to the dose-dependent anti-obesity effect of taurine
(Fig. 2). In the absence of taurine, the normal (N2)
strains sensitively responded to the high-fat diet via fat
accumulation in a dose-dependent manner. Unlike in
the staining experiment, however, the tub-1 mutant
positively responded to taurine by showing a lower tri-
glyceride content under the taurine treatment. The
inconsistency between the staining and the quantitation
results in the tubby worms implies that taurine may
work in the stage of fat biosynthesis rather than in the
stage of fat accumulation.
The taurine treatment did not alter the food consumption
assay of the worms
No considerable difference was seen between the worms
that were treated with taurine and the worms in the
taurine-free conditions. Fig. 3 shows little or no differ-
ence between the taurine-treated worms and the non-
taurine-treated control, although the starved and the
Figure 1 Sudan black B staining of taurine-treated worms. C. elegans were treated with taurine for 24 h and its effect on lipid storage was
observed by Sudan black B staining. The taurine’s effect on reduction of lipid accumulation was significant in the wild type strain of N2.
However, the effect of taurine was minimal or insignificant for the lipid storage mutant, tub-1.
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time of their complete food consumption. This observa-
tion indicates that taurine may not affect worms’ craving
for food, and thus, the potential anti-obesity function of
taurine does not stem from the suppression of food
ingestion.
The worms became active under taurine treatment
After the tunicamycin-treated worms were further
g r o w no nt a u r i n e - c o n t a i n i n g media, the extents of the
worms’ movement after various treatment concentra-
tions were visually compared (Fig. 4). The visual
comparison of the worms’ tracks revealed that the taur-
ine-treated worms travelled longer distances than the
non-taurine-treated control( T a b l e1 . ) .T h ep o s i t i v e
effect of taurine on mobility may contribute to the
reduction of lipid accumulation in C. elegans. Taurine’s
effect was more pronounced when the worms were trea-
ted with more taurine.
Discussion
Using C. elegans systems, this study tested taurine’s
potential as an anti-obesity agent by helping reduce lipid
accumulation in cells. Taurine significantly decreased fat
storage depending on its concentration. Without nega-
tively affecting food intake, taurine showed substantially
reduced fat accumulation and increased activity, which
matched the reduction of lipid storage under its
treatment.
Complex cellular mechanisms coordinate the equili-
brium between lipid utilization and accumulation
[21-23]. Being critical for the utilization of stored lipids,
beta-oxidation converts fatty acids to acetyl co-A and
requires the release of fatty acids from triacylglycerides
by lipases [24-27]. The increased activity of the worms
after the taurine treatment strongly suggests that the
lesser accumulation of fat was due to the higher level of
beta-oxidation from the taurine-enhanced activities of
the C. elegans.
One of the findings in this study is that taurine had
only a minor anti-obesity effect on the tub-1 mutant,
unlike on the normal strain. Unlike the wild type, the
tubby mutants are known to store more fat due to their
inability to control excessive transport to fat storage tis-
sues or to react properly to metabolic signals from
ciliated neurons [28,29]. Thus, taurine’s potential anti-
obesity effect is not applicable to the lipid accumulation
stage or is independent of the pathways where tub-1 is
involved.
The Sudan black B staining and triglyceride assays
showed inconsistent results concerning the tub-1
mutants in response to taurine. That is, the Sudan black
Figure 2 Triglyceride content measurement. The high fat grown
N2 worms positively responded to the taurine treatment in a dose-
dependent manner when the triglyceride content was measured as
described in Methods. The response of tub-1, however, showed no
significance compared to N2.
Figure 3 Food consumption assay. The time taken for the total consumption of OP50 was compared among the taurine treatments. A
significant difference was observed between starved (A) and well-fed (B) worms; however, no significance was noticed between the taurine
treatments within the strain. The x-axis refers to the time (min) taken for a total consumption of food.
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application, but the triglyceride content measurements
showed a significant difference between the taurine-free
and the taurine-treated worms. These inconsistent
results strongly indicate that the taurine had a more
immediate impact on lipid deposition than on fat
synthesis.
As in mammals, C. elegans accumulates fat both from
its diet and via de novo biosynthesis, and stores lipids in
subcellular compartments. Not enough information is
available, however, on how C. elegans acquires, synthe-
sizes, uses, and stores lipids, but the consistent results
o ft h i ss t u d yi n d i c a t et h a tt aurine diminishes lipid sto-
rage by enhancing physical activities, rather than by
reducing food uptake. Despite these data, the mechan-
i s mb e h i n dt h es u b c e l l u l a rt a r g e t i n ga n ds e q u e s t r a t i o n
that dictate the magnitude and numbers of these depos-
its remains to be determined.
Conclusions
In summary, this study showed that taurine affects lipid
deposition in a dose-dependent manner. Reduced lipid
storage was evident in the wild-type worms but not in
the tub-1 mutants. Unlike tub-1, N2 positively
responded to taurine according to its triglyceride con-
tent assay. The increased mobility with the taurine treat-
ment may contribute to reduced lipid deposition via
enhanced lipid consumption. An additional study is
necessary to clarify the potential mechanisms for the fat
storage reduction. A new study may be rewarding in
finding a definite agent that would modulate tub-1/kat-1
and sbp-1 molecules. Collective treatment of these
molecules with taurine is a good way to generally cope
with obesity.
List of abbreviations used
SREBP: sterol regulatory element-binding protein; TAB: triglyceride assay
buffer; kat-1: 3-ketoacyl-CoA thiolase-1; NGM: nematode growth media.
Acknowledgements
This article has been published as part of Journal of Biomedical Science
Volume 17 Supplement 1, 2010: Proceedings of the 17th International
Meeting of Taurine. The full contents of the supplement are available online
at http://www.jbiomedsci.com/supplements/17/S1.
We appreciate Dong-A Pharmaceutical Company for providing materials
including taurine. We also thank the Molecular Biology Lab students for
confirming the data by repeating the experiments in this study.
Author details
1Department of Life Sciences, University of Seoul, Dongdaemun-Gu, Seoul,
130-743, Korea.
2College of Agriculture and Science, Chungnam National
University, Yuseong, Daejeon, 305-764, Korea.
Authors’ contributions
HMK maintained C. elegans and carried out the various taurine treatments
and data collection. CHD participated in the design of the study and
performed the statistical analysis. DHL participated in obtaining worm strains
and coordination and helped to draft the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Published: 24 August 2010
References
1. Tsuboyama-Kasaoka N, Shozawa C, Sano K, Kamei Y, Kasaoka S,
Hosokawa Y, Ezaki O: Taurine (2-aminoethanesulfonic acid) Deficiency
Creates a Vicious Circle Promoting Obesity. Endocrinology 2006,
147:3276-3284.
2. Zhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S:
Beneficial effects of taurine on serum lipids in overweight or obese non-
diabetic subjects. Amino acids 2004, 26:267-271.
3. Chiang SH, MacDougald OA: Will fatty worms help cure human obesity?
Trends in Genetics 2003, 19:523-525.
4. McKay RM, McKay JP, Avery L, Graff JM: C elegans: a model for exploring
the genetics of fat storage. Dev Cell 2003, 4:131-142.
5. Wagner GP: The developmental genetics of homology. Nat Rev Genet
2007, 8:473-479.
6. Leung KF, Baron R, Seabra MC: Thematic review series: Lipid
posttranslational modifications. J Lipid Res Geranylgeranylation of Rab
GTPases 2006, 47:467-475.
7. Ashrafi K: Obesity and the regulation of fat metabolism. WormBook 2007,
1-20.
8. Watts JL, Browse J: Genetic dissection of polyunsaturated fatty acid
synthesis in Caenorhabditis elegans. Proc Natl Acad Sci U. S. A 2002,
99:5854-5859.
9. Suh JM, Zeve D, McKay R, Seo J, Salo Z, Li R, Wang M, Graff JM: Adipose is
a conserved dosage-sensitive antiobesity gene. Cell Metab 2007,
6:195-207.
10. Falk M, Zhang Z, Rosenjack J, Nissim I, Daikhin E, Nissim I, Sedensky MM,
Yudko M, Morgan PG: Metabolic pathway profiling of mitochondrial
respiratory chain mutants in C. elegans. Mol Genet Metab 2008,
93:388-397.
11. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J, Ruvkun G:
Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory
genes. Nature 2003, 421:268-272.
12. Brock TJ, Browse J, Watts JL: Fatty acid desaturation and the regulation of
adiposity in Caenorhabditis elegans. Genetics 2007, 176:865-875.
13. Mak HY, Nelson LS, Basson M, Johnson CD, Ruvkun G: Polygenic control of
Caenorhabditis elegans fat storage. Nature Genetics 2006, 38:363-368.
14. Mak HY, Ruvkun G: Intercellular signaling of reproductive development
by the C. elegans DAF-9 cytochrome P450. Development 2004,
131:1777-1787.
15. Schroeder LK, Kremer S, Kramer MJ, Currie E, Kwan E, Watts JL,
Lawrenson AL, Hermann GJ: Function of the Caenorhabditis elegans ABC
transporter PGP-2 in the biogenesis of a lysosome-related fat storage
organelle. Mol. Biol Cell 2007, 18:995-1008.
16. Weaver TE, Na CL, Stahlman M: Biogenesis of lamellar bodies, lysosome-
related organelles involved in storage and secretion of pulmonary
surfactant. Semin Cell Dev. Biol 2002, 13:263-270.
17. Taubert S, Van Gilst MR, Hansen M, Yamamoto KR: A Mediator subunit,
MDT-15, integratesregulation of fatty acid metabolism by NHR-49-
dependent and-independent pathways in C. elegans. Genes Dev 2006,
20:1137-1149.
Table 1 Motility comparison assay
[Taurine]
Strain 01 5 1 0 ( μg/ml)
N2 d
0 d
++ d
+++ d
+++
tub-1 d
0 d
+ d
0 d
+
Worms were grown on taurine-containing or free media. The distance of
worm’s movement was compared among the taurine treatments. “d
o” refers
to the distance the worms moved on the taurine–free media. “+” denotes an
approximate 10% increase in mobility according to the length of path left on
the media.
Kim et al. Journal of Biomedical Science 2010, 17(Suppl 1):S33
http://www.jbiomedsci.com/content/17/S1/S33
Page 5 of 618. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM: Peroxisome-
proliferator-activated receptor delta activates fat metabolism to prevent
obesity. Cell 2003, 113:159-170.
19. Desvergne B, Michalik L, Wahli W: Transcriptional regulation of
metabolism. Physiol Rev 2006, 86:465-514.
20. Narbonne P, Roy R: Caenorhabditis elegans dauers need LKB1/AMPK to
ration lipid reserves and ensure long-term survival. Nature 2008,
457:210-214.
21. Wang MC, O’Rourke EJ, Ruvkun G: Fat metabolism links germline stem
cells and longevity in C. elegans. Science 2008, 322:957-960.
22. Mashek DG, Coleman RA: Cellular fatty acid uptake: the contribution of
metabolism. Curr Opin Lipidol 2006, 17:274-278.
23. Larsen MK, Tuck S, Faergeman NJ, Knudsen J: MAA-1, a novel acyl-CoA-
binding protein involved in endosomal vesicle transport in
Caenorhabditis elegans. Mol Biol Cell 2006, 17:4318-4329.
24. Resh MD: Trafficking and signaling by fatty-acylated and prenylated
proteins. Nat Chem Biol 2006, 2:584-590.
25. Mukhopadhyay A, Deplancke B, Walhout JM, Tissenbaum HA: C. elegans
tubby regulates life span and fat storage by two independent
mechanisms. Cell Metab 2005, 2:35-42.
26. Houthoofd K, Braeckman BP, Johnson TE, Vanfleteren JR: No reduction of
metabolic rate in food restricted Caenorhabditis elegans. Exp Gerontol
2002, 37:1359-1369.
27. Ware RW, Crossland K, Russell RL, Clark DV: The nerve ring of the
nematode C elegans: Sensory input and motor output. J Comp Neurol
1975, 162:71-110.
28. Lewis JA, Hodgkin JA: Specific neuroanatomical changes in
chemosensory mutants of the nematode Caenorhabditis elegans. J
Comp Neurol 1977, 172(3):489-510.
29. Douglas SJ, Dawson-Scully K, Sokolowski MB: The neurogenetics and
evolution of food-related behaviour. Trends Neurosci 2005, 28(12):644-652.
doi:10.1186/1423-0127-17-S1-S33
Cite this article as: Kim et al.: Characterization of taurine as anti-obesity
agent in C. elegans. Journal of Biomedical Science 2010 17(Suppl 1):S33.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kim et al. Journal of Biomedical Science 2010, 17(Suppl 1):S33
http://www.jbiomedsci.com/content/17/S1/S33
Page 6 of 6